Scotiabank Increases Knight Therapeutics Inc (GUD) Price Target to C$11.00

Knight Therapeutics Inc (TSE:GUD) had its target price lifted by research analysts at Scotiabank from C$10.50 to C$11.00 in a research note issued to investors on Friday. The firm presently has an “outperform” rating on the stock. Scotiabank’s target price indicates a potential upside of 8.91% from the company’s current price.

Other equities research analysts have also recently issued research reports about the stock. CIBC decreased their target price on shares of Knight Therapeutics from C$13.00 to C$9.80 in a research note on Friday, January 13th. National Bank Financial raised their target price on shares of Knight Therapeutics from C$11.00 to C$11.75 in a research note on Wednesday, March 15th. TD Securities restated a “buy” rating and set a C$12.50 target price on shares of Knight Therapeutics in a research note on Tuesday, March 14th. Finally, Mackie cut shares of Knight Therapeutics from a “buy” rating to a “hold” rating and decreased their target price for the stock from C$12.00 to C$10.75 in a research note on Wednesday, January 4th. Two analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. The stock presently has an average rating of “Buy” and an average target price of C$11.16.

Analyst Recommendations for Knight Therapeutics (TSE:GUD)

Shares of Knight Therapeutics (TSE:GUD) opened at 10.10 on Friday. The company has a market capitalization of $1.34 billion and a price-to-earnings ratio of 71.13. Knight Therapeutics has a one year low of $7.20 and a one year high of $11.03. The stock has a 50 day moving average of $10.56 and a 200-day moving average of $9.93.

Your IP Address:

About Knight Therapeutics

Knight Therapeutics Inc is a Canada-based pharmaceutical company. The Company is engaged in developing, acquiring, in-licensing, out-licensing, marketing and distributing pharmaceutical products, consumer health products and medical devices in Canada and select international markets. It finances other life sciences companies in Canada and internationally.

Receive News & Ratings for Knight Therapeutics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Knight Therapeutics Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Nike Suspends Relationship with Maria Sharapova
Nike Suspends Relationship with Maria Sharapova
Rob Bironas Ex-Titans Kicker Dies in Car Crash
Rob Bironas Ex-Titans Kicker Dies in Car Crash
Ron Washington Leaves Texas Rangers Due to an Affair
Ron Washington Leaves Texas Rangers Due to an Affair
Jonathan Dwyer Falls in Line with Other Banned NFL Players
Jonathan Dwyer Falls in Line with Other Banned NFL Players
Tony Stewart Case Going to the Grand Jury
Tony Stewart Case Going to the Grand Jury
Oscar Pistorius “Blade Runner” Found Not Guilty of Murder
Oscar Pistorius “Blade Runner” Found Not Guilty of Murder


Leave a Reply

 
© 2006-2017 Web Breaking News.